Simplex Trading
BDSX icon

Simplex Trading’s Biodesix BDSX Stock Holding History

Simplex Trading’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-160
Closed -$4K – 8475
2024
Q2 		$4K Buy
160
+10
+7% +$286 ﹤0.01% 7948
2024
Q1 		$4K Buy
+150
New +$5.13K ﹤0.01% 8087

Other funds holding BDSX

TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.2B AUM 18.37% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Simplex Trading's BDSX Position: Q1 2025 in Review

Simplex Trading sold out of Biodesix (BDSX) in Q1 2025, closing a stake of 4 shares — an estimated $77 sold.

Simplex Trading first reported a position in BDSX in Q4 2021 and held it in 9 quarters. The position peaked at $5K in Q4 2022. 59 funds tracked by Wall St. Rank hold BDSX as of Q1 2025.

  • Simplex Trading reported no remaining Biodesix position as of Q1 2025 after selling out during the quarter.
  • Simplex Trading sold 4 Biodesix shares in Q1 2025, an estimated $77.
  • Simplex Trading first reported a position in Biodesix in Q4 2021 and held it in 9 quarters.
  • Simplex Trading's Biodesix position peaked at $5K in Q4 2022.
  • 59 funds tracked by Wall St. Rank held Biodesix as of Q1 2025.

Based on Simplex Trading's 13F filing for Q1 2025, filed 12 May 2025.